The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lateral Epicondylitis Treatment Market Research Report 2024
Synopsis
Lateral epicondylitis is prevalent among patients suffering from osteoarthritis, bursa inflammation, and radio-humeral bursitis.
The global Lateral Epicondylitis Treatment market was valued at US$ 11290 million in 2023 and is anticipated to reach US$ 14430 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
Due to an increase in the number of sporting events and competitions, particularly in the United States, the burden of sports-related lateral epicondylitis injuries is increasing in this population. This is expected to increase the demand for various treatment options that can help reduce pain and improve cure rates.
This report aims to provide a comprehensive presentation of the global market for Lateral Epicondylitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lateral Epicondylitis Treatment.
Report Scope
The Lateral Epicondylitis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lateral Epicondylitis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lateral Epicondylitis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer AG
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc.
Merck Sharp & Dohme Corp.
Pfizer Inc.
DJO Global, Inc.
Teikoku Pharma USA, Inc
Zimmer Biomet
3M
AKSIGEN
BTL
Johari Digital
Ossur Corporate
OttoBock HealthCare
Veritas Health LLC
Segment by Type
Non-surgical treatment
Surgical treatment
Segment by Application
Athlete
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lateral Epicondylitis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Lateral epicondylitis is prevalent among patients suffering from osteoarthritis, bursa inflammation, and radio-humeral bursitis.
The global Lateral Epicondylitis Treatment market was valued at US$ 11290 million in 2023 and is anticipated to reach US$ 14430 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
Due to an increase in the number of sporting events and competitions, particularly in the United States, the burden of sports-related lateral epicondylitis injuries is increasing in this population. This is expected to increase the demand for various treatment options that can help reduce pain and improve cure rates.
This report aims to provide a comprehensive presentation of the global market for Lateral Epicondylitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lateral Epicondylitis Treatment.
Report Scope
The Lateral Epicondylitis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lateral Epicondylitis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lateral Epicondylitis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer AG
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc.
Merck Sharp & Dohme Corp.
Pfizer Inc.
DJO Global, Inc.
Teikoku Pharma USA, Inc
Zimmer Biomet
3M
AKSIGEN
BTL
Johari Digital
Ossur Corporate
OttoBock HealthCare
Veritas Health LLC
Segment by Type
Non-surgical treatment
Surgical treatment
Segment by Application
Athlete
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lateral Epicondylitis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lateral Epicondylitis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Non-surgical treatment
1.2.3 Surgical treatment
1.3 Market by Application
1.3.1 Global Lateral Epicondylitis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Athlete
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lateral Epicondylitis Treatment Market Perspective (2019-2030)
2.2 Lateral Epicondylitis Treatment Growth Trends by Region
2.2.1 Global Lateral Epicondylitis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Lateral Epicondylitis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Lateral Epicondylitis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Lateral Epicondylitis Treatment Market Dynamics
2.3.1 Lateral Epicondylitis Treatment Industry Trends
2.3.2 Lateral Epicondylitis Treatment Market Drivers
2.3.3 Lateral Epicondylitis Treatment Market Challenges
2.3.4 Lateral Epicondylitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lateral Epicondylitis Treatment Players by Revenue
3.1.1 Global Top Lateral Epicondylitis Treatment Players by Revenue (2019-2024)
3.1.2 Global Lateral Epicondylitis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Lateral Epicondylitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lateral Epicondylitis Treatment Revenue
3.4 Global Lateral Epicondylitis Treatment Market Concentration Ratio
3.4.1 Global Lateral Epicondylitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lateral Epicondylitis Treatment Revenue in 2023
3.5 Lateral Epicondylitis Treatment Key Players Head office and Area Served
3.6 Key Players Lateral Epicondylitis Treatment Product Solution and Service
3.7 Date of Enter into Lateral Epicondylitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lateral Epicondylitis Treatment Breakdown Data by Type
4.1 Global Lateral Epicondylitis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Lateral Epicondylitis Treatment Forecasted Market Size by Type (2025-2030)
5 Lateral Epicondylitis Treatment Breakdown Data by Application
5.1 Global Lateral Epicondylitis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Lateral Epicondylitis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Lateral Epicondylitis Treatment Market Size (2019-2030)
6.2 North America Lateral Epicondylitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Lateral Epicondylitis Treatment Market Size by Country (2019-2024)
6.4 North America Lateral Epicondylitis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lateral Epicondylitis Treatment Market Size (2019-2030)
7.2 Europe Lateral Epicondylitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Lateral Epicondylitis Treatment Market Size by Country (2019-2024)
7.4 Europe Lateral Epicondylitis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lateral Epicondylitis Treatment Market Size (2019-2030)
8.2 Asia-Pacific Lateral Epicondylitis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Lateral Epicondylitis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Lateral Epicondylitis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lateral Epicondylitis Treatment Market Size (2019-2030)
9.2 Latin America Lateral Epicondylitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Lateral Epicondylitis Treatment Market Size by Country (2019-2024)
9.4 Latin America Lateral Epicondylitis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lateral Epicondylitis Treatment Market Size (2019-2030)
10.2 Middle East & Africa Lateral Epicondylitis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Lateral Epicondylitis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Lateral Epicondylitis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Detail
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Lateral Epicondylitis Treatment Introduction
11.1.4 Bayer AG Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.1.5 Bayer AG Recent Development
11.2 GlaxoSmithKline plc.
11.2.1 GlaxoSmithKline plc. Company Detail
11.2.2 GlaxoSmithKline plc. Business Overview
11.2.3 GlaxoSmithKline plc. Lateral Epicondylitis Treatment Introduction
11.2.4 GlaxoSmithKline plc. Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.2.5 GlaxoSmithKline plc. Recent Development
11.3 Johnson & Johnson Services, Inc.
11.3.1 Johnson & Johnson Services, Inc. Company Detail
11.3.2 Johnson & Johnson Services, Inc. Business Overview
11.3.3 Johnson & Johnson Services, Inc. Lateral Epicondylitis Treatment Introduction
11.3.4 Johnson & Johnson Services, Inc. Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.3.5 Johnson & Johnson Services, Inc. Recent Development
11.4 Merck Sharp & Dohme Corp.
11.4.1 Merck Sharp & Dohme Corp. Company Detail
11.4.2 Merck Sharp & Dohme Corp. Business Overview
11.4.3 Merck Sharp & Dohme Corp. Lateral Epicondylitis Treatment Introduction
11.4.4 Merck Sharp & Dohme Corp. Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.4.5 Merck Sharp & Dohme Corp. Recent Development
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Detail
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Lateral Epicondylitis Treatment Introduction
11.5.4 Pfizer Inc. Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.5.5 Pfizer Inc. Recent Development
11.6 DJO Global, Inc.
11.6.1 DJO Global, Inc. Company Detail
11.6.2 DJO Global, Inc. Business Overview
11.6.3 DJO Global, Inc. Lateral Epicondylitis Treatment Introduction
11.6.4 DJO Global, Inc. Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.6.5 DJO Global, Inc. Recent Development
11.7 Teikoku Pharma USA, Inc
11.7.1 Teikoku Pharma USA, Inc Company Detail
11.7.2 Teikoku Pharma USA, Inc Business Overview
11.7.3 Teikoku Pharma USA, Inc Lateral Epicondylitis Treatment Introduction
11.7.4 Teikoku Pharma USA, Inc Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.7.5 Teikoku Pharma USA, Inc Recent Development
11.8 Zimmer Biomet
11.8.1 Zimmer Biomet Company Detail
11.8.2 Zimmer Biomet Business Overview
11.8.3 Zimmer Biomet Lateral Epicondylitis Treatment Introduction
11.8.4 Zimmer Biomet Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.8.5 Zimmer Biomet Recent Development
11.9 3M
11.9.1 3M Company Detail
11.9.2 3M Business Overview
11.9.3 3M Lateral Epicondylitis Treatment Introduction
11.9.4 3M Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.9.5 3M Recent Development
11.10 AKSIGEN
11.10.1 AKSIGEN Company Detail
11.10.2 AKSIGEN Business Overview
11.10.3 AKSIGEN Lateral Epicondylitis Treatment Introduction
11.10.4 AKSIGEN Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.10.5 AKSIGEN Recent Development
11.11 BTL
11.11.1 BTL Company Detail
11.11.2 BTL Business Overview
11.11.3 BTL Lateral Epicondylitis Treatment Introduction
11.11.4 BTL Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.11.5 BTL Recent Development
11.12 Johari Digital
11.12.1 Johari Digital Company Detail
11.12.2 Johari Digital Business Overview
11.12.3 Johari Digital Lateral Epicondylitis Treatment Introduction
11.12.4 Johari Digital Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.12.5 Johari Digital Recent Development
11.13 Ossur Corporate
11.13.1 Ossur Corporate Company Detail
11.13.2 Ossur Corporate Business Overview
11.13.3 Ossur Corporate Lateral Epicondylitis Treatment Introduction
11.13.4 Ossur Corporate Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.13.5 Ossur Corporate Recent Development
11.14 OttoBock HealthCare
11.14.1 OttoBock HealthCare Company Detail
11.14.2 OttoBock HealthCare Business Overview
11.14.3 OttoBock HealthCare Lateral Epicondylitis Treatment Introduction
11.14.4 OttoBock HealthCare Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.14.5 OttoBock HealthCare Recent Development
11.15 Veritas Health LLC
11.15.1 Veritas Health LLC Company Detail
11.15.2 Veritas Health LLC Business Overview
11.15.3 Veritas Health LLC Lateral Epicondylitis Treatment Introduction
11.15.4 Veritas Health LLC Revenue in Lateral Epicondylitis Treatment Business (2019-2024)
11.15.5 Veritas Health LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
